Is IDEV a good investment?

iShares Core MSCI International Developed Markets ETF (IDEV) is a developed ex-US international ETF. As of September 11, 2026, ETF Copilot scores IDEV 5.3 out of 10 — highest on Risk (7.7), lowest on Valuation (2.8). It trades at 17.5 times earnings, against its own median of 14.3. Its ten largest holdings are 11% of the fund.

Updated September 11, 2026

How is IDEV rated? ETF Copilot scores iShares Core MSCI International Developed Markets ETF (IDEV) 5.3 out of 10

As of September 11, 2026, ETF Copilot scores iShares Core MSCI International Developed Markets ETF (IDEV) 5.3 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

Overall: 5.3 / 10
Growth: 6.3 / 10
Valuation: 2.8 / 10
Risk: 7.7 / 10
Quality: 4.3 / 10
Return: 5.2 / 10

What is IDEV's expense ratio? 0.04% a year

As of September 11, 2026, IDEV charges 0.04% a year, yields 2.77% and holds $32.9B in assets across 2255 positions.

iShares Core MSCI International Developed Markets ETF (IDEV) — cost, income and size
Measure	IDEV
Expense ratio	0.04%
Dividend yield	2.77%
Assets under management	$32.9B
Holdings	2255

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

What stands out in IDEV's data

Broad ex-U.S. developed-market equities, weighted by market cap.

Priced above its own history and the typical peer — you pay more for the same earnings today.

Trailing P/E multiple of 17.5x sits above the 16.5x category median and its own 14.3x five-year average. Holdings 2,255 names for 0.04% a year.

The core international sleeve of a portfolio, built for broad developed-market exposure.

Why did IDEV move this week? It fell 1.7% in the week to September 11, 2026 — Novartis and Shopify drove it

IDEV fell 1.7% in the week to September 11, 2026. The holdings that moved it most were Novartis (−15.2%), Shopify (−11.5%) and Novo Nordisk A/S-B (−9.3%); Softbank (+33.0%) pushed the other way.

Is IDEV expensive right now? It trades at 17.5 times earnings, against its own median of 14.3

As of September 11, 2026, IDEV is more expensive than 93% of its own 111 monthly readings since 2017 — 103 of those months were cheaper than today.

Trailing twelve-month, computed by ETF Copilot from the fund's holdings rather than quoted from a data provider, and rebuilt nightly.

What's inside IDEV? 13% Tech

What's inside IDEV: Size (Large 61%, Mid 26%, Small 13%); Geography (International 93%, US 7%); Tech 12.5%; AI 0.9%; Semiconductors 4.9%; Memory 1.8%.

What are IDEV's top holdings? The ten largest are 11% of the fund

ASML, HSBC, Roche, Royal Bank of Canada, Shell, Novartis, Mitsubishi UFJ Financial, Nestle, AstraZeneca and BHP are IDEV's largest holdings, in that order.

Less concentrated than 73% of Developed ex-US ETFs.

Half of IDEV's weight sits in its 123 largest positions, and once those weights are taken into account it behaves like 303 equally weighted holdings.

Cite this

ETF Copilot, “iShares Core MSCI International Developed Markets ETF (IDEV) scores and holdings analysis”, as of September 11, 2026.
https://etf-copilot.com/etf/idev